|Appears in Collections:||Biological and Environmental Sciences Journal Articles|
|Peer Review Status:||Unrefereed|
|Title:||Biodiversity, drug discovery, and the future of global health: Introducing the biodiversity to biomedicine consortium, a call to action|
Awan, Almas Taj
Cruz, Thomas Edison dela
Johnson, Mari-Vaughn V
Konevega, Andrey L
Malone, John H
|Citation:||Neergheen-Bhujun V, Awan AT, Baran Y, Bunnefeld N, Chan K, Cruz TEd, Egamberdieva D, Elsasser S, Johnson MV, Komai S, Konevega AL, Malone JH, Mason P, Nguon R & Piper R (2017) Biodiversity, drug discovery, and the future of global health: Introducing the biodiversity to biomedicine consortium, a call to action, Journal of Global Health, 7 (2), Art. No.: 020304.|
|Abstract:||First paragraph: Looking to nature for medicine is nothing new – we have been doing it for tens of thousands of years and although modern pharmaceutical science has come a long way from those ancient roots, nature is and will always be an important source of useful compounds and inspiration. Dismissing nature in this regard is a huge mistake as evolution is the greatest problem solver and the myriad compounds produced by the immense variety of species we share the planet with have been honed by three billion years of trial and error. However, with every bit of habitat that disappears under the plough or concrete we impoverish nature and deprive ourselves of potential medicines.|
|Rights:||This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).|
|Notes:||Additional co-authors: Uttam Babu Shrestha, Milica Pešić, Alexander Kagansky|
This item is protected by original copyright
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
If you believe that any material held in STORRE infringes copyright, please contact email@example.com providing details and we will remove the Work from public display in STORRE and investigate your claim.